3.74
price up icon7.16%   0.25
after-market Dopo l'orario di chiusura: 3.81 0.07 +1.87%
loading
Precedente Chiudi:
$3.49
Aprire:
$3.49
Volume 24 ore:
420.65K
Relative Volume:
0.99
Capitalizzazione di mercato:
$320.07M
Reddito:
$351.37M
Utile/perdita netta:
$-174.01M
Rapporto P/E:
-1.8068
EPS:
-2.07
Flusso di cassa netto:
$-126.94M
1 W Prestazione:
+8.09%
1M Prestazione:
+10.65%
6M Prestazione:
+18.35%
1 anno Prestazione:
-2.35%
Intervallo 1D:
Value
$3.4825
$3.82
Intervallo di 1 settimana:
Value
$3.36
$3.82
Portata 52W:
Value
$2.455
$4.145

Atea Pharmaceuticals Inc Stock (AVIR) Company Profile

Name
Nome
Atea Pharmaceuticals Inc
Name
Telefono
857-204-8109
Name
Indirizzo
225 FRANKLIN STREET, BOSTON
Name
Dipendente
56
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
AVIR's Discussions on Twitter

Confronta AVIR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
AVIR
Atea Pharmaceuticals Inc
3.74 293.54M 351.37M -174.01M -126.94M -2.07
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-13 Aggiornamento Morgan Stanley Underweight → Equal-Weight
2023-08-10 Downgrade JP Morgan Neutral → Underweight
2022-01-06 Downgrade Morgan Stanley Equal-Weight → Underweight
2021-11-18 Downgrade SVB Leerink Outperform → Mkt Perform
2021-10-20 Downgrade JP Morgan Overweight → Neutral
2021-10-05 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-11-25 Iniziato Evercore ISI Outperform
2020-11-24 Iniziato JP Morgan Overweight
2020-11-24 Iniziato Morgan Stanley Overweight
2020-11-24 Iniziato William Blair Outperform
Mostra tutto

Atea Pharmaceuticals Inc Borsa (AVIR) Ultime notizie

pulisher
Jul 24, 2025

What analysts say about Atea Pharmaceuticals Inc. stock outlookHigh-velocity gains - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Will Atea Pharmaceuticals Inc. stock benefit from interest rate changesExceptional profit margins - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Atea Pharmaceuticals Inc. stock priceUnprecedented profit potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Atea Pharmaceuticals Inc. stockFree High-Return Strategy Alerts - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Atea Pharmaceuticals Insiders Placed Bullish Bets Worth US$5.40m - Yahoo.co

Jul 23, 2025
pulisher
Jul 23, 2025

Atea Pharmaceuticals Inc. Stock Analysis and ForecastDynamic investment growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Atea Pharmaceuticals Inc. a good long term investmentFree Investment Community - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 15, 2025

Why Atea Pharmaceuticals Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Atea Pharmaceuticals Inc. stock price move sharplyFree Stock Portfolio Optimization - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Atea Pharmaceuticals Inc. stock performs during market volatilityFree Stock Movement Tracking - Newser

Jul 15, 2025
pulisher
Jun 29, 2025

Atea Pharmaceuticals announces continued advancement of global Phase 3 HCV program - European AIDS Treatment Group

Jun 29, 2025
pulisher
Jun 26, 2025

Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing - Bain Capital

Jun 26, 2025
pulisher
Jun 24, 2025

New Hepatitis C Treatment Could Slash Therapy Time to 8 Weeks as Global Phase 3 Trial Advances - Stock Titan

Jun 24, 2025
pulisher
Jun 20, 2025

Atea Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 20, 2025
pulisher
Jun 17, 2025

Here's Why We're Not At All Concerned With Atea Pharmaceuticals' (NASDAQ:AVIR) Cash Burn Situation - Yahoo Finance

Jun 17, 2025
pulisher
Jun 15, 2025

Bank of America Corp DE Boosts Stock Position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Invests $75,000 in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 14, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Buys 35,053 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Shares Sold by Two Sigma Investments LP - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Jane Street Group LLC Decreases Stock Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Public Employees Retirement System of Ohio Trims Stock Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Ameriprise Financial Inc. Sells 11,900 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

ProShare Advisors LLC Buys 6,163 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Layoff Tracker: Keros Cuts 45% of Workforce Along With Pulmonary Hypertension Drug - BioSpace

Jun 02, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Buys New Shares in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

May 27, 2025
pulisher
May 26, 2025

Northern Trust Corp Boosts Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

May 26, 2025
pulisher
May 24, 2025

D. E. Shaw & Co. Inc. Purchases 62,505 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

May 24, 2025
pulisher
May 24, 2025

Wall Street Zen Upgrades Atea Pharmaceuticals (NASDAQ:AVIR) to “Hold” - Defense World

May 24, 2025
pulisher
May 17, 2025

Price T Rowe Associates Inc. MD Purchases 3,882 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

May 17, 2025

Atea Pharmaceuticals Inc Azioni (AVIR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):